Posterior Segment Bioavailability

Posterior Segment Bioavailability is the bioavailability of ophthalmic drugs specifically within the posterior segment of the eye, distinguished from anterior segment bioavailability by its focus on the vitreous humor, retina, and choroid, where drug delivery is hindered by ocular barriers and systemic absorption.

5

Publications

459

Citations

32

Authors

9

Institutions

Publications per year

2017–2026

1

Authors

32

  1. DH
    Dayle H. Geroski

    Emory University, United States

    1 publications · 342 citations

    1

    h-index

  2. HL
    Haoyan Li

    Chinese Academy of Sciences, China

    1 publications · 17 citations

    1

    h-index

  3. YY
    Yoshiko Yamazaki

    Nippon Shokubai (Japan), Japan

    1 publications · 37 citations

    1

    h-index

  4. JE
    James E. Chastain

    Alcon (United States), United States

    1 publications · 52 citations

    1

    h-index

  5. LC
    Leith C. R. Meyer

    University of the Witwatersrand, South Africa

    1 publications · 11 citations

    1

    h-index

1–5 of 32

Venues

  1. Materials Today Bio

    1 publications · 17 citations

    1

    h-index

  2. PubMed

    Repository · 1 publications · 342 citations

    1

    h-index

  3. Experimental Eye Research

    1 publications · 52 citations

    1

    h-index

  4. Current Eye Research

    1 publications · 37 citations

    1

    h-index

  5. Journal of Pharmaceutical Sciences

    1 publications · 11 citations

    1

    h-index

1–5